BACKGROUND: The Women's Health Initiative Dietary Modification (DM) Trial was a randomized controlled trial that compared the effects of a low-fat (≤20% of total energy) or a usual diet in relation to chronic disease risk in postmenopausal women. OBJECTIVE: We characterized long-term body-composition changes associated with the DM trial and potential modifiers of these associations. DESIGN: In the DM trial, 48,835 women aged 50-79 y were randomly assigned to intervention (40%) or comparison (60%) groups. We studied a subset with whole-body dual-energy X-ray absorptiometry scans at baseline and during follow-up. Changes in fat mass (FM), lean mass (LM), and percentage body fat between the intervention (n = 1580) and comparison (n = 2731) groups at years 1, 3, and 6 were compared. By using generalized estimating equations, we calculated overall differences between groups and tested for interactions with age, diabetes, race-ethnicity (white, black, and Hispanic), body mass index (BMI), and hormone therapy (HT). RESULTS: The intervention women experienced significantly greater reductions in percentage body fat, FM, and LM at years 1 and 3 than did women in the comparison group (all P < 0.05). At year 6, only the FM change was significantly different between groups. Overall, the intervention was associated with reductions in percentage body fat (-0.8%; 95% CI: -1.0%, -0.6%), FM (-1.1 kg; 95% CI: -1.3, -0.8 kg), and LM (-0.17 kg; 95% CI: -0.28, -0.06 kg) during follow-up (all P < 0.003). Intervention associations varied by race-ethnicity, BMI, diabetes, and HT and remained significant after adjustment for physical activity. CONCLUSION: This intervention was associated with modest long-term body-composition changes; the findings were more robust in years 1 and 3. This trial was registered at clinicaltrials.gov as NCT00000611.
RCT Entities:
BACKGROUND: The Women's Health Initiative Dietary Modification (DM) Trial was a randomized controlled trial that compared the effects of a low-fat (≤20% of total energy) or a usual diet in relation to chronic disease risk in postmenopausal women. OBJECTIVE: We characterized long-term body-composition changes associated with the DM trial and potential modifiers of these associations. DESIGN: In the DM trial, 48,835 women aged 50-79 y were randomly assigned to intervention (40%) or comparison (60%) groups. We studied a subset with whole-body dual-energy X-ray absorptiometry scans at baseline and during follow-up. Changes in fat mass (FM), lean mass (LM), and percentage body fat between the intervention (n = 1580) and comparison (n = 2731) groups at years 1, 3, and 6 were compared. By using generalized estimating equations, we calculated overall differences between groups and tested for interactions with age, diabetes, race-ethnicity (white, black, and Hispanic), body mass index (BMI), and hormone therapy (HT). RESULTS: The intervention women experienced significantly greater reductions in percentage body fat, FM, and LM at years 1 and 3 than did women in the comparison group (all P < 0.05). At year 6, only the FM change was significantly different between groups. Overall, the intervention was associated with reductions in percentage body fat (-0.8%; 95% CI: -1.0%, -0.6%), FM (-1.1 kg; 95% CI: -1.3, -0.8 kg), and LM (-0.17 kg; 95% CI: -0.28, -0.06 kg) during follow-up (all P < 0.003). Intervention associations varied by race-ethnicity, BMI, diabetes, and HT and remained significant after adjustment for physical activity. CONCLUSION: This intervention was associated with modest long-term body-composition changes; the findings were more robust in years 1 and 3. This trial was registered at clinicaltrials.gov as NCT00000611.
Authors: Barbara V Howard; JoAnn E Manson; Marcia L Stefanick; Shirley A Beresford; Gail Frank; Bobette Jones; Rebecca J Rodabough; Linda Snetselaar; Cynthia Thomson; Lesley Tinker; Mara Vitolins; Ross Prentice Journal: JAMA Date: 2006-01-04 Impact factor: 56.272
Authors: J L Clasey; M L Hartman; J Kanaley; L Wideman; C D Teates; C Bouchard; A Weltman Journal: Med Sci Sports Exerc Date: 1997-04 Impact factor: 5.411
Authors: Shirley A A Beresford; Karen C Johnson; Cheryl Ritenbaugh; Norman L Lasser; Linda G Snetselaar; Henry R Black; Garnet L Anderson; Annlouise R Assaf; Tamsen Bassford; Deborah Bowen; Robert L Brunner; Robert G Brzyski; Bette Caan; Rowan T Chlebowski; Margery Gass; Rosanne C Harrigan; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Jane Morley Kotchen; Lewis H Kuller; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Cora E Lewis; JoAnn E Manson; Karen L Margolis; Yasmin Mossavar-Rahmani; Judith K Ockene; Linda M Parker; Michael G Perri; Lawrence Phillips; Ross L Prentice; John Robbins; Jacques E Rossouw; Gloria E Sarto; Marcia L Stefanick; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Evelyn Whitlock Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: Barbara V Howard; Linda Van Horn; Judith Hsia; JoAnn E Manson; Marcia L Stefanick; Sylvia Wassertheil-Smoller; Lewis H Kuller; Andrea Z LaCroix; Robert D Langer; Norman L Lasser; Cora E Lewis; Marian C Limacher; Karen L Margolis; W Jerry Mysiw; Judith K Ockene; Linda M Parker; Michael G Perri; Lawrence Phillips; Ross L Prentice; John Robbins; Jacques E Rossouw; Gloria E Sarto; Irwin J Schatz; Linda G Snetselaar; Victor J Stevens; Lesley F Tinker; Maurizio Trevisan; Mara Z Vitolins; Garnet L Anderson; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Bette Caan; Rowan T Chlebowski; Margery Gass; Iris Granek; Philip Greenland; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; F Allan Hubbell; Karen C Johnson; Jane Morley Kotchen Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: Ross L Prentice; Bette Caan; Rowan T Chlebowski; Ruth Patterson; Lewis H Kuller; Judith K Ockene; Karen L Margolis; Marian C Limacher; JoAnn E Manson; Linda M Parker; Electra Paskett; Lawrence Phillips; John Robbins; Jacques E Rossouw; Gloria E Sarto; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Sylvia Wassertheil-Smoller; Evelyn Whitlock; Katsuhiko Yano; Lucile Adams-Campbell; Garnet L Anderson; Annlouise R Assaf; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Leslie Ford; Margery Gass; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Jane Morley Kotchen; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Maureen M Henderson Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: Paula Brauer; Sarah Connor Gorber; Elizabeth Shaw; Harminder Singh; Neil Bell; Amanda R E Shane; Alejandra Jaramillo; Marcello Tonelli Journal: CMAJ Date: 2015-01-26 Impact factor: 8.262
Authors: Cynthia A Thomson; Linda Van Horn; Bette J Caan; Aaron K Aragaki; Rowan T Chlebowski; JoAnn E Manson; Thomas E Rohan; Lesley F Tinker; Lewis H Kuller; Lifang Hou; Dorothy S Lane; Karen C Johnson; Mara Z Vitolins; Ross L Prentice Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-09-25 Impact factor: 4.254
Authors: James M Shikany; Karen L Margolis; Mary Pettinger; Rebecca D Jackson; Marian C Limacher; Simin Liu; Lawrence S Phillips; Lesley F Tinker Journal: Am J Clin Nutr Date: 2011-05-11 Impact factor: 7.045
Authors: Li Jiao; Liang Chen; Donna L White; Lesley Tinker; Rowan T Chlebowski; Linda V Van Horn; Peter Richardson; Dorothy Lane; Haleh Sangi-Haghpeykar; Hashem B El-Serag Journal: J Natl Cancer Inst Date: 2018-01-01 Impact factor: 13.506
Authors: Phyllis J Goodman; Jo Ann Hartline; Catherine M Tangen; John J Crowley; Lori M Minasian; Eric A Klein; Elise D Cook; Amy K Darke; Kathryn B Arnold; Karen Anderson; Monica Yee; Frank L Meyskens; Laurence H Baker Journal: Clin Trials Date: 2012-10-12 Impact factor: 2.486
Authors: Matthew A Allison; Aaron Aragaki; Charles Eaton; Wenjun Li; Linda Van Horn; Martha L Daviglus; Jeffrey S Berger Journal: Stroke Date: 2014-04-17 Impact factor: 7.914
Authors: Carolyn J Crandall; Kathleen M Hovey; Christopher A Andrews; Jane A Cauley; JoAnn E Manson; Jean Wactawski-Wende; Nicole C Wright; Wenjun Li; Kristen Beavers; Jeffrey R Curtis; Meryl S LeBoff Journal: J Clin Endocrinol Metab Date: 2015-09-14 Impact factor: 5.958